InvestorsHub Logo
Followers 64
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: extrooper post# 423900

Sunday, 12/05/2021 10:15:49 AM

Sunday, December 05, 2021 10:15:49 AM

Post# of 704072
Extrooper, rhetorical question, but you can answer it if you wish. The point of a rhetorical question is that you know the answer or it is one where there is no right answer.

Why would anyone be willing to put money on the opposite side of the equation here and the answer to that explains everything?

Also, this timeline we sit right here in the midst of is by no means outside the realm of typical from the viewpoint of regulatory approval and has several months before any questions should realistically be made. For Europe and all that Jazz, a few more years.

What is out of whack is the timeline for TLD release. Why would anyone do that? There are basically two answers her, but add in manufacturing expansion by a conflicted company and LL never wavering one bit in her belief that the next step is adding to DCVax, not finding an alternative. That simply is coordination with company to add value to the product, AND the other choice involves activity which would be a case for jurors to decide.

I choose option one full, global approval pending. Those outside the current network either historically align quickly or are not worth the time and effort to do so.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News